A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

The Wu administration is considering dropping GLP-1 coverage for weight loss for City of Boston employees due to ...

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

A study finds heart benefits of GLP-1 drugs may fade after stopping treatment, while generics could soon lower costs in some ...

A new study shows the heart health benefits of popular GLP-1 weight loss drugs may begin to fade soon after patients stop ...

RALEIGH, N.C. (WNCN) — It’s National Poison Prevention Week, just as North Carolina Poison Control officials say there’s an increase in calls about GLP-1 drugs. CBS 17 Investigates reported last month ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...